|
|
|
Volumn 146, Issue 5, 2003, Pages
|
|
Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
DRUG DERIVATIVE;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
PADGEM PROTEIN;
TICLOPIDINE;
TIROFIBAN;
TYROSINE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
STENT;
THROMBOCYTE;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION;
VASCULAR ENDOTHELIUM;
ANTIBODIES, MONOCLONAL;
ASPIRIN;
BLOOD PLATELETS;
CORONARY DISEASE;
DRUG THERAPY, COMBINATION;
ENDOTHELIUM, VASCULAR;
FEMALE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MIDDLE AGED;
P-SELECTIN;
PLATELET ACTIVATION;
PLATELET AGGREGATION;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROSPECTIVE STUDIES;
STENTS;
TICLOPIDINE;
TYROSINE;
|
|
EID: 1542391517
PISSN: None
EISSN: 10976744
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|
